Page last updated: 2024-12-05

1,2,3,5-tetrachlorobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2,3,5-tetrachlorobenzene is an organic compound with the formula C6H2Cl4. It's a colorless solid that is practically insoluble in water but soluble in organic solvents like benzene and chloroform.

**Importance in Research:**

1,2,3,5-tetrachlorobenzene is **not widely studied** and has **limited practical applications**. However, it's important for research in the following areas:

* **Environmental Chemistry:** It's a **model compound** for studying the **persistence and bioaccumulation of chlorinated aromatic compounds** in the environment. This is because it's structurally similar to more prevalent environmental pollutants like polychlorinated biphenyls (PCBs).
* **Spectroscopy:** It's used as a **reference material** for calibrating instruments used in **Raman spectroscopy and nuclear magnetic resonance (NMR) spectroscopy**. This is because its spectral properties are well-characterized.
* **Organic Synthesis:** It can serve as a **starting material** for synthesizing other chlorinated aromatic compounds, which might have potential uses in various fields.

**However, it's important to note that 1,2,3,5-tetrachlorobenzene is a potentially toxic substance, and proper safety precautions should be taken when handling it.**

**In summary, 1,2,3,5-tetrachlorobenzene is primarily used as a model compound and a reference material in scientific research. It's not a widely studied or commercially significant compound, but it plays a role in advancing our understanding of environmental chemistry and spectroscopic techniques.**

1,2,3,5-tetrachlorobenzene : A tetrachlorobenzene carrying chloro groups at positions 1, 2, 3 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12468
CHEMBL ID44011
CHEBI ID36696
SCHEMBL ID358001
MeSH IDM0096138

Synonyms (52)

Synonym
AC-20114
unii-i27n186cin
i27n186cin ,
1,2,3,5-tetrachlorobenzene
benzene, 1,2,3,5-tetrachloro-
1,2,3,5-tetrachlorbenzol
CHEBI:36696 ,
inchi=1/c6h2cl4/c7-3-1-4(8)6(10)5(9)2-3/h1-2
nsc-78934
1,3,5-tetrachlorobenzene
nsc78934
benzene,2,3,5-tetrachloro-
634-90-2
NCGC00090896-01
ai3-18219
einecs 211-217-7
nsc 78934
hsdb 4269
brn 1618864
ccris 5936
NCIOPEN2_004420
1,2,3,5-tetrachloro-benzene
CHEMBL44011
T0870
A834399
1,2,3,5-tetrakis(chloranyl)benzene
NCGC00090896-02
63697-21-2
dtxcid606089
cas-634-90-2
NCGC00258227-01
tox21_200673
dtxsid1026089 ,
FT-0602561
AKOS015889831
1,2,4,6-tetrachlorobenzene
1,2,3,5-tetrachlorobenzene [hsdb]
SCHEMBL358001
2199-74-8
1,2,3,5-tetrachlorobenzene-d2
QZYNWJQFTJXIRN-UHFFFAOYSA-N
mfcd00000543
1,2,3,5-tetrachlorobenzene, pestanal(r), analytical standard
1,2,3,5-tetrachlorobenzene 100 microg/ml in methanol
1,2,3,5-tetrachlorobenzene 10 microg/ml in cyclohexane
benzene, 1,2,3,5-tetrachloro-; 1,2,3,5-tetrachlorobenzene; 1,2,4,6-tetrachlorobenzene; nsc 78934
F21454
1,3,4,5-tetrachlorobenzene
Q27116931
AS-13405
AMY14359
EN300-155369

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Results indicate that 1,2,4,5-TCB is the most toxic isomer of the three and accumulates in liver and fat in a dose-dependent manner."( Toxicity of 1,2,3,4-, 1,2,3,5- and 1,2,4,5-tetrachlorobenzene in the rat: results of a 90-day feeding study.
Chu, I; Secours, VE; Valli, VE; Villeneuve, DC, 1984
)
0.27
" LD50 values for 1,2,3,4-, 1,2,4,5-, and 1,2,3,5-TCB were found to be 1470, 3105, and 2297 mg/kg, respectively, in male rats."( Comparative toxicity of 1,2,3,4-, 1,2,4,5-, and 1,2,3,5-tetrachlorobenzene in the rat: results of acute and subacute studies.
Chu, I; Secours, V; Valli, VE; Villeneuve, D,
)
0.39
" 1,2,4,5-TeCB was neither lethal, nor produced any perceptible adverse effects, at lipid normalized concentrations predicted to be lethal according to the well-established critical body residue concept."( Differential acute toxicity of tetrachlorobenzene isomers to oligochaetes in soil and water: application of the critical body residue concept.
Hurdzan, CM; Lanno, RP; Sovic, DM, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tetrachlorobenzeneAny member of the class of chlorobenzenes carrying four chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency5.35970.006038.004119,952.5996AID1159521
AR proteinHomo sapiens (human)Potency56.34400.000221.22318,912.5098AID743036; AID743040; AID743053
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency12.58930.011212.4002100.0000AID1030
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency31.97880.003041.611522,387.1992AID1159552; AID1159555
estrogen nuclear receptor alphaHomo sapiens (human)Potency28.13950.000229.305416,493.5996AID588513; AID743075; AID743079
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency50.11870.001019.414170.9645AID588537
Nuclear receptor ROR-gammaHomo sapiens (human)Potency0.09440.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID162229Toxicity determined using Konemann's Industrial Pollutants Toxicity Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (35.71)18.7374
1990's5 (35.71)18.2507
2000's2 (14.29)29.6817
2010's2 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.05 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.24 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]